Search | IOVS | ARVO Journals

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Clinical factors associated with response to dexamethasone intravitreal implant in DME recalcitrant to bevacizumab.

Pradeep Prasad; Diana Lee; Michael Javaheri

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):400. doi:

ARVO Annual Meeting Abstract June 2013

One Year Clinical Outcomes Of A Randomized Clinical Trial Investigating Pre-operative Adjunctive Bevacizumab For Tractional Retinal Detachment (TRD) Due To Proliferative Diabetic Retinopathy (PDR)

Elizabeth Tegins; Michael Javaheri; Dean Eliott; Leo Kim; Hani Salehi-Had; David Hinton; Elliott Sohn

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5785. doi:

ARVO Annual Meeting Abstract April 2011

Randomized, Double-Masked, Controlled Translational Investigation Of Bevacizumab For Retinal Detachment Due To Proliferative Diabetic Retinopathy

Elliott H. Sohn; Dean Eliott; Shikun He; Leo Kim; Hani Salehi-Had; Michael Javaheri; Chris Spee; Laurie Dustin; David Hinton

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):981. doi:

Advertisement